2m 2m 2m 2m 2m 2m 2m
LivaNova (LIVN)
NASDAQ
$78.65-$0.06 (-0.08%)
Price as of Jun 23, 2026 6:51 PM EDT- $4.3BMarket Cap
- 72.72%1-Year Change
- Medical DevicesIndustry
LivaNova (LIVN)
$78.65-$0.06 (-0.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4B +10.74% | 1.3B +8.66% | 1.2B +12.89% | 1.0B -1.31% | |
Cost of Revenue | 448.2M +17.15% | 382.6M +0.07% | 382.3M +21.53% | 314.6M -4.49% | |
Gross Profit | 939.9M +7.92% | 870.9M +12.92% | 771.3M +9.05% | 707.2M +0.17% | |
Sales and Marketing Expense | 548.8M +4.28% | 526.3M +1.57% | 518.1M +10.42% | 469.2M -0.56% | |
Research and Development Expense | -185.8M +1.78% | -182.5M -5.83% | -193.8M +24.40% | -155.8M -15.05% | |
Depreciation and Amortization Expense | 17.7M -29.49% | 25.1M +1.48% | 24.7M +10.57% | 22.4M -8.82% | |
Total Operating Expenses | 448.2M +17.15% | 382.6M +0.07% | 382.3M +21.53% | 314.6M -4.49% | |
Operating Profit | 199.4M +54.50% | 129.1M +288.40% | -68.5M -10.75% | -76.8M +9,689.80% | |
Interest Income | -3.6M -150.70% | 7.1M -67.54% | 22.0M +368.64% | 4.7M +979.77% | |
Interest Expense | N/A N/A | N/A N/A | -58.9M +21.98% | -48.3M -3.79% | |
Interest Income and Expense and Net | -3.6M -150.70% | 7.1M +119.39% | -36.8M -15.41% | -43.6M -12.40% | |
Total Nonoperating Income and Expense | -2.7M -364.40% | 1.0M -98.28% | 58.9M +21.98% | 48.3M -3.79% | |
Income before Taxes | -220.8M -350.01% | 88.3M +208.72% | -81.2M +8.10% | -75.1M -39.63% | |
Income Taxes | 21.6M -13.64% | 25.1M +125.34% | -98.9M -994.72% | 11.1M -1.31% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -242.5M -483.45% | 63.2M +260.39% | 17.5M +120.34% | -86.2M -36.50% | |
Net Income from Continuing Operations Applicable to Common | -242.5M -483.45% | 63.2M +260.39% | 17.5M +120.34% | -86.2M -36.50% | |
Basic EPS and Net Income | -4.45 -480.34% | 1.17 +254.55% | 0.33 +120.50% | -1.61 -39.93% | |
Diluted EPS and Net Income | -4.45 -483.62% | 1.16 +262.50% | 0.32 +119.88% | -1.61 -39.93% | |
Basic Weighted Average Shares | 54.5M +0.57% | 54.2M +0.56% | 53.9M +0.87% | 53.5M +5.61% | |
Diluted Weighted Average Shares | 54.5M -0.05% | 54.6M +0.67% | 54.2M +1.38% | 53.5M +5.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 635.6M +48.20% | 428.9M +60.92% | 266.5M +24.43% | 214.2M +2.97% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 635.6M +48.20% | 428.9M +60.92% | 266.5M +24.43% | 214.2M +2.97% | |
Total Current Assets | 1.1B -2.27% | 1.1B +14.07% | 988.2M +11.51% | 886.1M +30.47% | |
Accumulated Depreciation | 242.2M +17.15% | 206.8M +5.47% | 196.0M +11.94% | 175.1M +8.24% | |
Property and Plant and Equipment and Net | 242.6M +42.49% | 170.3M +10.43% | 154.2M +4.75% | 147.2M -1.92% | |
Total Long-Term Assets | 15.7M +11.02% | 14.1M +17.15% | 12.1M -25.68% | 16.2M +23.88% | |
Total Assets | 2.6B +3.98% | 2.5B +3.16% | 2.4B +5.87% | 2.3B +4.26% | |
Income Taxes Payable | 42.7M -1.49% | 43.4M +24.25% | 34.9M +39.51% | 25.0M +9.41% | |
Total Short-Term Debt | 31.5M -59.65% | 78.0M +330.70% | 18.1M -22.71% | 23.4M -89.80% | |
Total Current Liabilities | 808.1M +106.08% | 392.1M +17.06% | 335.0M +12.64% | 297.4M -57.33% | |
Total Long-Term Debt | 345.2M -37.20% | 549.6M -3.33% | 568.5M +9.74% | 518.1M +5,160.10% | |
Total Long-Term Liabilities | 55.4M +24.49% | 44.5M -6.81% | 47.7M +4.10% | 45.8M -8.13% | |
Total Liabilities | 1.4B +18.54% | 1.2B +2.97% | 1.2B +5.96% | 1.1B +19.95% | |
Retained Earnings | -1.1B +26.84% | -903.3M -6.54% | -966.5M -1.78% | -984.0M +9.61% | |
Total Stockholders Equity | 1.2B -9.11% | 1.3B +3.34% | 1.3B +5.80% | 1.2B -6.72% | |
Total Shares Outstanding | 54.6M +0.55% | 54.3M +0.80% | 53.9M +0.66% | 53.6M +0.57% | |
Cash Flow | |||||
Cash from Operating Activities | 254.3M +38.95% | 183.0M +144.33% | 74.9M +7.14% | 69.9M -31.81% | |
Capital Expenditures | 81.0M +72.06% | 47.1M +34.66% | 35.0M +31.92% | 26.5M +4.08% | |
Cash from Investing Activities | -72.9M +51.40% | -48.2M +19.41% | -40.3M +4.99% | -38.4M -204.09% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -285.7M -1,639.86% | 18.6M -13.65% | 21.5M -92.33% | 280.1M +254.36% | |
Financials Ratio | |||||
Gross Margin | 67.71% -2.54% | 69.48% +3.92% | 66.86% -3.40% | 69.21% +1.50% | |
Operating Margin | 14.36% +39.52% | 10.30% +273.39% | -5.94% -20.95% | -7.51% +9,822.59% | |
Return on Assets | -9.49% -470.21% | 2.56% +244.94% | 0.74% +119.36% | -3.84% -34.85% | |
Return on Equity | -19.24% -495.27% | 4.87% +244.77% | 1.41% +120.48% | -6.89% -38.75% | |
Revenue Growth | 10.74% +24.02% | 8.66% -32.83% | 12.89% +1,084.42% | -1.31% -112.10% | |
Current Ratio | 1.36 -52.57% | 2.87 -2.55% | 2.95 -1.00% | 2.98 +205.76% | |
Cash Ratio | 0.79 -28.09% | 1.09 +37.47% | 0.80 +10.47% | 0.72 +141.35% | |
Debt-to-Equity Ratio | 0.31 -33.97% | 0.48 +3.53% | 0.46 +2.41% | 0.45 +142.38% | |
Debt-to-Assets Ratio | 0.14 -42.29% | 0.25 +3.69% | 0.24 +2.33% | 0.24 +116.91% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow